our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 28 September 2015

    Antares Pharma Announces Publication of Quickshot Testosterone in Prestigious Health Journal
  • 24 September 2015

    Antares Pharma to Present at the Ladenburg Thalmann 2015 Healthcare Conference
  • 10 August 2015

    Antares Pharma Reports Second Quarter 2015 Financial and Operating Results
  • 4 August 2015

    Antares Pharma Announces First Patients Enrolled in Quickshot Testosterone Supplemental Safety Study
  • 3 August 2015

    Antares Pharma to Host Second Quarter 2015 Operating and Financial Results Call
  • 14 July 2015

    Antares Pharma Appoints Peter J. Graham ESQ., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>